Triphenylphosphine → 4-[3-(3-Nitro-phenyl)-4-pyridin-4-yl-pyrazol-1-yl]-piperidine-1-carboxylic acid tert-butyl ester
反応式
[N+:1]([C:4]1[CH:5]=[C:6]([C:10]2[C:14]([C:15]3[CH:20]=[CH:19][N:18]=[CH:17][CH:16]=3)=[CH:13][NH:12][N:11]=2)[CH:7]=[CH:8][CH:9]=1)([O-:3])=[O:2].C1(P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.[C:40]([O:44][C:45]([N:47]1[CH2:52][CH2:51][CH:50](O)[CH2:49][CH2:48]1)=[O:46])([CH3:43])([CH3:42])[CH3:41].CCOC(/N=N/C(OCC)=O)=O.C1(P(=O)(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1>O1CCCC1>[C:40]([O:44][C:45]([N:47]1[CH2:52][CH2:51][CH:50]([N:12]2[CH:13]=[C:14]([C:15]3[CH:20]=[CH:19][N:18]=[CH:17][CH:16]=3)[C:10]([C:6]3[CH:7]=[CH:8][CH:9]=[C:4]([N+:1]([O-:3])=[O:2])[CH:5]=3)=[N:11]2)[CH2:49][CH2:48]1)=[O:46])([CH3:43])([CH3:41])[CH3:42]参加物
7
反応物 5
生成物 1
試薬・触媒・溶媒 1
実験手順
To a suspension of 4-[3-(3-nitro-phenyl)-1H-pyrazol-4-yl]-pyridine (200 mg, 0.750 mmol) in anhydrous tetrahydrofuran (3 mL) at 0° C. triphenylphosphine (293 mg, 1.12 mmol, 1.5 eq), 4-hydroxy-piperidine-1-carboxylic acid tert-butyl ester (150 mg, 0.750 mmol, 1 eq) and DEAD (176 μL, 1.12 mmol, 1.5 eq) were added. The reaction was allowed to warm to room temperature and stirred under nitrogen atmosphere overnight. The regioisomeric ratio was 1:4 at 254 nm in favor of the N1-alkylated product. The solvent was removed under reduced pressure and the residue was purified by silica gel column chromatography (DCM/ethanol 97:3) to give 950 mg of major regioisomer contaminated with triphenylphosphinoxide.
後処理
- additionwere added
- customThe solvent was removed under reduced pressure
- customthe residue was purified by silica gel column chromatography (DCM/ethanol 97:3)
- customto give 950 mg of major regioisomer
出典と根拠
- ORDレコード
- ord-6f1ca0bdcdcf4fc3a65086352d29c924
- 出典データセット
- uspto-grants-2015_02
- 特許番号
- US08946250B2
反応ノート
読み込み中…